CompletedNCT00018850
5HT3 Antagonism and Auditory Gating in Schizophrenia
Medication studyAges 18–55United States
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
- Listed locations
- DenverSee all locations and recruitment
Study information
Study start dateJune 1998
- Recruitment status
- Completed
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- US Department of Veterans Affairs
- Sponsor type
- Government agency
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT00018850
- Official title
Show the full official title
5HT3 Antagonism and Auditory Gating in Schizophrenia
Recruitment & locations
CompletedDenver
Questions about this study
Who is behind this study?
The study sponsor is US Department of Veterans Affairs.
Did this study involve medication?
Yes. The study involved medication, including ondansetron, nicotine and haloperidol.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me